Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis

Ticker
CTKB

Price
4.20
Stock movement down
-0.04 (-0.94%)
Company name
Cytek Biosciences Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Medical Devices
Market cap
537.03M
Ent value
565.98M
Price/Sales
2.67
Price/Book
1.57
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
93.33
PEG
-
EPS growth
-
1 year return (CAGR)
-19.54%
3 year return (CAGR)
-30.90%
5 year return (CAGR)
-
10 year return (CAGR)
-
Last updated: 2026-03-13

DIVIDENDS

CTKB does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales2.67
Price to Book1.57
EV to Sales2.81

FINANCIALS

Per share

Loading...
Per share data
Current share count127.86M
EPS (TTM)-0.52
FCF per share (TTM)-0.07

Income statement

Loading...
Income statement data
Revenue (TTM)201.49M
Gross profit (TTM)104.46M
Operating income (TTM)-40.38M
Net income (TTM)-66.54M
EPS (TTM)-0.52
EPS (1y forward)0.04

Margins

Loading...
Margins data
Gross margin (TTM)51.84%
Operating margin (TTM)-20.04%
Profit margin (TTM)-33.02%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash90.85M
Net receivables62.51M
Total current assets392.00M
Goodwill16.70M
Intangible assets16.82M
Property, plant and equipment0.00
Total assets461.54M
Accounts payable6.41M
Short/Current long term debt14.04M
Total current liabilities77.80M
Total liabilities119.80M
Shareholder's equity341.74M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-4.69M
Capital expenditures (TTM)4.08M
Free cash flow (TTM)-8.77M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-19.47%
Return on Assets-14.42%
Return on Invested Capital-18.83%
Cash Return on Invested Capital-2.48%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open4.17
Daily high4.32
Daily low4.10
Daily Volume663K
All-time high27.93
1y analyst estimate6.00
Beta1.31
EPS (TTM)-0.52
Dividend per share0.00
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
CTKBS&P500
Current price drop from All-time high-84.96%-1.82%
Highest price drop-91.34%-56.47%
Date of highest drop23 May 20259 Mar 2009
Avg drop from high-66.70%-10.84%
Avg time to new high128 days12 days
Max time to new high1110 days1805 days

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
CTKB (Cytek Biosciences Inc) company logo
Marketcap
537.03M
Marketcap category
Small-cap
Description
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle detection; Cytek amnis imagestream imaging flow cytometers; Cytek guava muse cell analyzers; Cytek muse micro cell analyzers; Cytek guava easyCyte flow cytometers; and Cytek orion reagent cocktail preparation systems. It also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments. In addition, the company offers automated micro-sampling system and automated sample loader system, an automated loaders designed to integrate seamlessly into the Cytek aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for Cytek aurora, northern lights, and Cytek aurora evo systems; and customer support tools. Further, it provides conventional flow and image-based flow cytometry instrumentation and related products and services under the Amnis and Guava brand names. The company serves pharmaceutical and biopharma companies, academic research centers, and contract research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in Europe, Latin America, and the Middle East countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
Employees
702
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...